Rabbit syndrome following discontinuation of paliperidone in a patient with schizoaffective disorder

Journal of Clinical Psychopharmacology

Volumn 32, Issue 5, 2012, Pages 720-721

  Liang, Chih Sung ^a   Yang, Fei Wen ^a   Huang, Yao Chin ^a  

^a Beitou Armed Forces Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BIPERIDEN; CARBAMAZEPINE; CLOZAPINE; CREATINE KINASE; CYTOCHROME P450 2D6; LITHIUM; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; VALPROIC ACID; ZOTEPINE;

ABNORMAL INVOLUNTARY MOVEMENT SCALE; ADULT; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; ENZYME ACTIVITY; HUMAN; LETTER; LITHIUM BLOOD LEVEL; MALE; NEUROLOGIC EXAMINATION; PARKINSONISM; PHARMACOGENOMICS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RABBIT SYNDROME; RATING SCALE; RECURRENT DISEASE; SCHIZOAFFECTIVE PSYCHOSIS;

ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; HUMANS; ISOXAZOLES; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; PSYCHOTIC DISORDERS; PYRIMIDINES; SUBSTANCE WITHDRAWAL SYNDROME; SYNDROME;

EID: 84865861799     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182683903     Document Type: Letter

References (10)

1. Gao K, Kemp DE, Ganocy SJ, et al. Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review. J Clin Psychopharmacol. 2008;28:203-209.
2. Teng PR, Lai TJ. Paliperidone-related rabbit syndrome. J Clin Psychopharmacol. 2011;31:379-380.
3. Guy W. Abnormal Involuntary Movement Scale (AIMS) in ECDEU Assessment Manual for Psychopharmacology. Washington, DC: US Government Printing Office; 1976:534-537.
4. Levin T, Heresco-Levy U. Risperidone-induced rabbit syndrome: an unusual movement disorder caused by an atypical antipsychotic. Eur Neuropsychopharmacol. 1999;9: 137-139.
5. Villeneuve A. The rabbit syndrome. A peculiar extrapyramidal reaction. Can Psychiatr Assoc J. 1972;17(suppl 2): 69-72.
6. Gerlach J, Reisby N, Randrup A. Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia. 1974;34:21-35.
7. Casey DE. Tardive dyskinesia. West J Med. 1990;153:535-541.
8. Canuso CM, Schooler N, Carothers J, et al. Paliperidone extended-release in schizoaffective disorder: a randomized, controlled study comparing a flexible dose with placebo in patients treated with and without antidepressants and/or mood stabilizers. J Clin Psychopharmacol. 2010;30:487-495.
9. Catena Dell'osso M, Fagiolini A, Ducci F, et al. Newer antipsychotics and the rabbit syndrome. Clin Pract Epidemiol Ment Health. 2007;3:6.
10. Nishimura K, Tsuka M, Horikawa N. Withdrawal-emergent rabbit syndrome during dose reduction of risperidone. Eur Neuropsychopharmacol. 2001;11:323-324.